13. July 2013

Report: 2nd quarter 2013


ChiroBlock successfully completed the first major projects in the business field “ReDesign Factory” in 2013.

Here, new, validated synthesis processes on lab scale have been developed which replaced older, less efficient ones.

One customer, for example, benefits from an improved hydrogenation procedure resulting in a substantial reduction of the noble catalyst load. Cost savings of two hundred thousand EUR per year are the positive outcome.

Another scientist was employed in April this year. With a research background from the Leibnitz Institute of Plant-biosciences and with industrial experiences in several US and European companies, he complements ChiroBlock’s R&D staff in an ideal way. He will strengthen our capabilities in the field of chemo enzymatic reactions.

The second quarter of 2013 also was a period of frequent and successful customer audits. As an example, ChiroBlock has qualified for the delivery of a critical supplement to a biotech process.

contact us

Cookie Setting: We use Cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our coporate commercial objectives, as well as other cookies which are used soley for anonymous statistical purposes, for more comfortable website settings, or for the display of personal content. You are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. You can always opt-out of our cookie settings. Further information can be found in our data policy.